The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma

Pathol Oncol Res. 2020 Oct;26(4):2831-2833. doi: 10.1007/s12253-020-00864-6. Epub 2020 Jun 29.

Stefan Hatzl¹, Florian Posch^{2

3}, Eduard Schulz⁴, Maximilian Gornicec⁴, Alexander Deutsch⁴, Christine Beham-Schmid⁵, Martin Pichler^{2

3

6

7}, Hildegard Greinix⁴, Heinz Sill⁴, Armin Zebisch^{4

8}, Peter Neumeister⁴, Katharina T Prochazka⁴

¹ Division of Hematology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 38D, A-8036, Graz, Austria. stefan.hatzl@medunigraz.at.
² Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
³ Center for Biomarker Research in Medicine (CBmed Ges.m.b.H.), Graz, Austria.
⁴ Division of Hematology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 38D, A-8036, Graz, Austria.
⁵ Institute of Pathology, Medical University of Graz, Graz, Austria.
⁶ Research Unit for Non-coding RNAs and Genome Editing, Medical University of Graz, Graz, Austria.
⁷ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁸ Otto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria.

No abstract available

Publication types